Orchard Therapeutics plc Annual Interest Expense in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Orchard Therapeutics plc quarterly/annual Interest Expense history and growth rate from 2019 to 2022.
  • Orchard Therapeutics plc Interest Expense for the quarter ending September 30, 2023 was $932K, a 16.6% increase year-over-year.
  • Orchard Therapeutics plc Interest Expense for the twelve months ending September 30, 2023 was $3.8M, a 34.2% increase year-over-year.
  • Orchard Therapeutics plc annual Interest Expense for 2022 was $3.08M, a 23.3% increase from 2021.
  • Orchard Therapeutics plc annual Interest Expense for 2021 was $2.5M, a 7.26% increase from 2020.
  • Orchard Therapeutics plc annual Interest Expense for 2020 was $2.33M, a 51.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.08M +$582K +23.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $2.5M +$169K +7.26% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $2.33M +$790K +51.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $1.54M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.